Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Kashiv Biosciences LLC , a fully integrated biopharmaceutical...

Related Keywords

India ,Chicago ,Illinois ,United States ,Israel ,South Korea ,Japan ,Hong Kong ,Ukraine ,Pakistan ,United Kingdom ,Philippines ,Thailand ,Bangladesh ,New Zealand ,Singapore ,Switzerland ,Indonesia ,Malaysia ,China ,Yangtze River ,China General ,Canada ,Australia ,Cambodia ,Vietnam ,Republic Of ,Taiwan ,Ahmedabad ,Gujarat ,Africa ,Robert Wessman ,Paras Vasanani ,Sandeep Gupta ,Saval Latin America ,Teva Pharmaceutical Industries Ltd ,Kashiv Biosciences ,Yangtze River Pharmaceutical Group Co Ltd ,Roche Ltd ,Kamada Ltd ,European Union ,Teva Pharmaceuticals ,Fuji Pharma Co Ltd Japan ,Lotus Pharmaceuticals Co Ltd ,Pharma Corporation Canada ,South America ,Teva Pharmaceutical Industries ,Advanz Pharma ,Cipla Med Pro ,Yangtze River Pharmaceutical ,Middle East ,North Africa ,Abdi Ibrahim ,Mega Labs ,Latin America ,Private Securities Litigation Reform Act ,Note Regarding Forward Looking ,Investor Relations ,Markets ,